SNBL Enters Pathology Consulting Agreement

SNBL USA has entered into a consulting agreement with Dr. Pritam Sahota of Global ToxPath, LLC. Dr. Sahota is a recognized industry leader in toxicologic pathology evaluations within pharmaceutical nonclinical safety assessment. This agreement allows SNBL to use Dr. Sahota’s expertise to augment its pathology services on an ongoing basis, with the goal of providing high-quality, on-time study conduct for clients.
 
Dr. Sahota has held various positions at Novartis including executive director of pathology and executive director of special preclinical safety projects. He has been responsible for anatomic, clinical, investigative and discovery pathology, including contracted studies, and has led special projects centered on cardiotoxicity, ocular toxicity, carcinogenicity, drug repositioning and patient centricity.
 
“SNBL USA takes great pride in providing the best service to our clients. This collaboration with Dr. Pritam Sahota allows us to capitalize on our combined and complementary expertise,” said Dr. Stewart Jacobson, SNBL USA director of pathology services. “We are very excited to have Pritam working with us to provide additional support with client study designs and program development, peer reviews and general pathologic expertise.”